|
OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. Clinical research trials and OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.. OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. clinical trial. Human subjects often receive the most effective healthcare possible for their OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.  OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
For Condition: Pancreatic Cancer
Status: No longer recruiting
Sponsor(s): OSI Pharmaceuticals , National Cancer Institute of Canada
Synopsis: The purpose of this study is to determine if OSI-774 will improve overall survival when combined with a standard dose of the chemotherapy drug gemcitabine, to individuals with pancreatic cancer.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Histologically or cytologically confirmed diagnosis of adenocarcinoma of the pancreas;cancer which is unresectable, locally advanced or metastatic. Must have evidence of disease (clinical or radiological). Male or female, 18 years or older. Patients may have received prior radiation treatment for management of local disease providing that disease progression has been documented. All toxicities have resolved, and the last fraction of radiation treatment was completed at least 4 weeks prior to randomization. Patients may not have received prior chemotherapy, other then 5FU (+/- folic acid) or gemcitabine given concurrently with radiation treatment as a 'radiosensitiser.'
Total Enrollment: 500
Location and Contact Information:
New England Medical Center
Boston, Massachusetts, 021111533
United States
Prince of Wales Hospital
Randwick, New South Wales, 2031
Australia
Azienda Ospedaliera Universitaria Policlinico A.O.V.P. Oncologia Medica
Palermo, , 90127
Italy
Kaplan Medical Center
Rehovot, ,
Israel
The Queen Elizabeth Hospital
Woodville South, South Australia, 5011
Australia
New York University School of Medicine
New York City, New York, 10016
United States
Universitatskliniken des Saarlands
Homburg, , 66421
Germany
University of Minnesota
Minneapolis, Minnesota, 55455
United States
University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, 19104
United States
Hospital Italiano
Buenos Aires, , CP 1181
Argentina
Hamilton Regional Cancer Centre
Hamilton, Ontario, L8V 5C2
Canada
Christie Hospital NHS Trust
Manchester, , M20 4BX
United Kingdom
MD Anderson Cancer Center
Houston, Texas, 77030
United States
Green Mountain Oncology Group
Bennington, Vermont, 05201
United States
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1
Canada
Berkshire Hematology & Oncology, PC
Pittsfield, Massachusetts, 012018298
United States
Concord Hospital
Concord, New South Wales, 2139
Australia
Nucleo de Oncolgia da Bahia
Salvador, BA, 40170-070
Brazil
London Regional Cancer Center
London, Ontario, N6A 4L6
Canada
National University Hospital
Singapore, , 119074
Singapore
Alta Bates Comprehensive Cancer Center
Berkeley, California, 94704
United States
UCLA Medical Center
Los Angeles, California, 90095
United States
Instituto Nacional De Cancerologia
Mexico City, , 14000
Mexico
Loma Linda University Cancer Institute
Loma Linda, California, 92354
United States
Atlanta Cancer Center
Atlanta, Georgia, 30342
United States
J Gurtler, Hematology and Oncology
Metairie, Louisiana, 70006
United States
BC Cancer Centre for the Southern Interior
Kelowna, British Columbia, V1Y 5L3
Canada
St. Bartholomews Hospital
London, , EC1A 7BE
United Kingdom
Clinica Las Condes
Las Condes, ,
Chile
Western Washington Oncology Inc.
Olympia, Washington, 98502
United States
Pennsylvania Oncology Hematology Associates
Philadelphia, Pennsylvania, 19106
United States
Onc/Hem Associates of Central Illinois
Peoria, Illinois, 61602
United States
Ashford Cancer Centre
Ashford, South Australia, 5035
Australia
Instituto Alexander Fleming
Buenos Aires, , CP 1426
Argentina
Chiles Research Cancer Center
Portland, Oregon, 97213-2967
United States
Newcastle Mater Hospital
HRMC Waratah, New South Wales, 2310
Australia
University Hospitals of Cleveland
Cleveland, Ohio, 44106-7832
United States
Universitatsklinikum Essen
ESSEN, , 45122
Germany
Dolnoslaskie Centrum Onkologii
Wroclaw, , 53-413
Poland
Kaiser Permanente
San Diego, California, 92120
United States
Tampa General Hospital
Tampa, Florida, 33606
United States
Hospital Britanico
Buenos Aires, , CP 1280
Argentina
Velindre Hospital
Cardiff, Wales, CF14 2TL
United Kingdom
Charleston Hematology/Oncology
Charleston, South Carolina, 29403
United States
Odyssey Research Services
Bismark, North Dakota, 58501
United States
Rambam Medical Center
Haifa, , 31096
Israel
Carl and Dorothy Bennett Cancer Center
Stamford, Connecticut, 06902-3628
United States
Irmandade Santa Casa de Misericordia de Porto Alegre
Porto Alegre, RS, CEP 90020-090
Brazil
Arlington Cancer Centre
Arlington, Texas, 76012
United States
Highlands Oncology Group
Springdale, Arkansas, 72764
United States
Arena Oncology Associates
Great Neck, New York, 11021
United States
Great Poland Cancer Centre
Poznan, , 61 866
Poland
Ocala Oncology
Ocala, Florida, 34474
United States
Fraser Valley Cancer Centre
Surrey, British Columbia, V3V 1Z2
Canada
Princess Margaret Hospital
Toronto, Ontario, M5G 2M9
Canada
Universitatskliniken des Saarlands Innere Medizin II
Hamburg, , 66421
Germany
Hotel Dieu Hospital
St. Catharines, Ontario, L2R 5K3
Canada
Austin & Repatriation Medical Centre
Heidelberg, Victoria, 3084
Australia
Sarah Cannon Cancer Center
Nashville, Tennessee, 37203
United States
QEII Health Sciences Centre
Halifax, Nova Scotia, B3H 1V7
Canada
Hospital Churruca Visca
Buenos Aires, , CP 1437
Argentina
Oncology Hematology Group of South Florida
Miami, Florida, 33176
United States
Presbyterian Hospital,
Charlotte, North Carolina, 28204
United States
Singapore General Hospital
Singapore, , 169608
Singapore
BCCA Vancouver Cancer Centre
Vancouver, British Columbia, V5Z 4E6
Canada
Arizona Clinical Research Center, Inc.
Tucson, Arizona, 85712
United States
Annapolis Medical Specialists
Annapolis, Maryland, 21401
United States
Institute Jules Bordet
Brussels, , 1000
Belgium
Sourasky Medical Center (Ichikov)
Tel Aviv, , 64239
Israel
Credit Valley Hospital
Mississauga, Ontario, L5M 2V8
Canada
Norton Healthcare, Inc.
Louisville, Kentucky, 40202
United States
Midwest Cancer Research Group, Inc
Skokie, Illinois, 60077
United States
Sinai Hospital
Baltimore, Maryland, 21215
United States
North Middlesex Hospital
London, , N18 1QX
United Kingdom
New Britain General Hospital
New Britain, Connecticut, 06050
United States
BCCA- Vancouver Island Centre
Victoria, British Columbia, V8R 6V5
Canada
Oncology Institute Ion Chiricuta
Cluj Napoca, , 3400
Romania
University of Kansas Medical Center
Kansas City, Kansas, 66160
United States
Hospital Vera Cruz S/A
Barro Preto, Minas Gerais, CEP 30190-130
Brazil
Stony Brook University Hospital
Stony Brook, New York, 11794-8174
United States
Oncology of Wisconsin
Milwaukee, Wisconsin, 53215
United States
Eastern Connecticut Oncology
Norwich, Connecticut, 06360-2910
United States
Instituto Oncologico Angel Roffo
Buenos Aires, , CP 1417
Argentina
National Cancer Centre
Singapore, , 169610
Singapore
Penticton Regional Hospital
Penticton, British Columbia, V2A 3G6
Canada
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2
Canada
Hopital Du Sacre-Coeur
Montreal, Quebec, H4J 2C5
Canada
Kingston Regional Cancer Centre
Kingston, Ontario, K7L 5P9
Canada
District General Hospital of Thessaloniki "HIPPOKRATION"
THESSALONIKI, , 546 39
Greece
Royal Adelaide Hospital
Adelaide, South Australia, 5000
Australia
Southwest Washington Medical Center
Vancouver, Washington, 98664
United States
Russell's Hall Hospital Department of Oncology Georgina Unit
Dudley, West Midlands, DY8 5QX
United Kingdom
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231
United States
Hospital Israelita Albert Einstein
Sao Paulo, SP, 05651-901
Brazil
Hopital Laval
Ste Foy, Quebec, G1V 4G5
Canada
Christchurch Hospital Clinical Oncology Hospital
Christchurch, ,
New Zealand
Metropolitan Hematology/Oncology Medical Group, Inc.
Los Angeles, California, 90057
United States
Rabin Medical Center (Belinson Campus)
Petach-Tiqva, , 49100
Israel
Toronto-Sunnybrook Regional Cancer Center
Toronto, Ontario, M4N 3M5
Canada
Medizinische Poliklinik der Universitaet Wurzburg
Wurzburg, , 97070
Germany
Newcastle General Hospital
Newcastle upon Tyne, , NE4 6BE
United Kingdom
Chaim Sheba Medical Center
Tel Hashomer, , 52621
Israel
Clinical County Hospital Sibiu
Sibiu, , 2400
Romania
CancerCare Manitoba (CCMB)
Winnipeg, Manitoba, R2H 2A6
Canada
University of Kentucky
Lexington, Kentucky, 40536-0098
United States
Hematology & Oncology Assoc of NE PA
Dunmore, Pennsylvania, 18512
United States
University of Iowa Hospital & Clinics
Iowa City, Iowa, 52242
United States
St Luke's-Roosevelt Hospital
New York City, New York, 10019
United States
Toronto East General Hospital
Toronto, Ontario, M4C 3E7
Canada
DeQuattro Community Cancer Center
Manchester, Connecticut, 06040
United States
New Hampshire Oncology-Hematology PA
Hooksett, New Hampshire, 03106
United States
St Barnabas Medical Center
Livingston, New Jersey, 07039
United States
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, 70809
United States
Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, A1B 3V6
Canada
Baystate Medical Center
Springfield, Massachusetts, 01107
United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
United States
Group Health Centre
Saulte Ste Marie, Ontario, P6B 1Y5
Canada
Churchill Hospital
Headington, Oxford, OX3 7LJ
United Kingdom
Uniklinik Heidelberg Medizinische Universitstsklinik
Heidelberg, , 69115
Germany
St Elizabeth Medical Center
Boston, Massachusetts, 01235
United States
Frankston Hospital
Frankston, Victoria, 3199
Australia
Upstate NY Cancer Research & Education Foundation
Rochester, New York, 14623
United States
The Princess Royal Hospital
Hull, , HU8 9HE
United Kingdom
St Joseph's Health Centre
Toronto, Ontario, M6R 1B5
Canada
St. Spiridon University Hospital
Iasi, , 6600
Romania
Centro Medico Confidence
Buenos Aires, , CP 1642
Argentina
Hopital Maisonneuve-Rosemont
Montreal, Quebec, H1T 2M4
Canada
Auckland Hospital
Auckland, , 92019
New Zealand
Tyler Hematology Oncology PA
Tyler, Texas, 75701
United States
Hematology & Oncology Associates of Virginia, Ltd.
Richmond, Virginia, 23226
United States
Saint John Regional Hospital
Saint John, New Brunswick, E2L 4L2
Canada
Anticancer Hospital of Thessaloniki "THEAGENIO"
THESSALONIKI, , 546 39
Greece
Southwest Regional Cancer Center
Austin, Texas, 78705
United States
Florida Cancer Specialists
Ft. Myers, Florida, 34135
United States
Charite Campus Virchow Klinikum
Berlin, , 13353
Germany
Oncology/Hematology Associates of Kansas City
Kansas City, Missouri, 64111
United States
Ottawa Regional Cancer Centre
Ottawa, Ontario, K1H 1C4
Canada
New Cross Hospital
Wolverhampton, , WV10 0QP
United Kingdom
Martin-Luther-Universitat Halle
Halle/Saale, , 06120
Germany
Carle Cancer Center
Urbana, Illinois, 61801
United States
Tumor Biology Center
Freiburg, , D-79106
Germany
Additional Information:
Study ID Numbers: OSI-774-PA3;
Study Start Date: October 2001
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00040183
Other Pancreatic Cancer Studies:
1. CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer
2. LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
3. Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
4. Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
5. Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
Related Studies:
Other Pancreatic Cancer Clinical Trials
Other Texas Clinical Trials
Other Arlington Clinical Trials
OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
|
|
|
|
|
|
|
|
